ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2231 • 2018 ACR/ARHP Annual Meeting

    An Ancestral-Specific Interaction of TRIM46 with a Past-History of Smoking May Influence Gout Risk

    Niamh Fanning1, Tony R. Merriman2, Amanda Phipps-Green2, John Pearson3, Ruth Topless2, Murray Cadzow2, Douglas White4, Nicola Dalbeth5 and Lisa K. Stamp6, 1Medicine, University of Otago, Christchurch, Christchurch, New Zealand, 2University of Otago, Dunedin, New Zealand, 3University of Otago, Christchurch, Christchurch, New Zealand, 4Department of Rheumatology, Waikato Clinical School, Hamilton, New Zealand, 5University of Auckland, Auckland, New Zealand, 6University of Otago, Christchurch, New Zealand

    Background/Purpose: Gout is caused by an interplay of genetic and environmental factors. Epidemiological and prospective studies suggest that current-smoking may be protective for developing gout…
  • Abstract Number: 2232 • 2018 ACR/ARHP Annual Meeting

    Prevalence of Gout in the Surviving U.S. Solid Organ Transplant Population

    Mark D. Brigham1, Thilan Tudor1, Gavin Miyasato1, Jeffrey D. Kent2, Brian LaMoreaux3 and Brian F. Mandell4, 1Trinity Partners, Waltham, MA, 2Medical Affairs, Horizon Pharma USA, Inc, Lake Forest, IL, 3Horizon Pharma USA, Inc, Lake Forest, IL, 4Rheumatology, Cleveland Clinic, Cleveland, OH

    Background/Purpose: Although incidence and survival are frequent topics within the solid organ transplant (SOT) literature, there are no recent publications on the total size of…
  • Abstract Number: 2233 • 2018 ACR/ARHP Annual Meeting

    Activation and Deficiency of Circulating Mucosal-Associated Invariant T Cells in Patients with Gouty Arthritis

    Yong-Wook Park1, Young-Nan Cho2, Hye-Mi Jin1 and Seung-Jung Kee3, 1Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), 2Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, MN, Korea, Republic of (South), 3Laboratory Medicine, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South)

    Background/Purpose: Mucosal-associated invariant T (MAIT) cells contribute to protection against certain microorganism infections and play an important role in mucosal immunity. Upon antigen recognition, MAIT…
  • Abstract Number: 2234 • 2018 ACR/ARHP Annual Meeting

    Liver Safety of Febuxostat Compared with Allopurinol in Gout Patients with Fatty Liver Disease

    Jung Sun Lee1, Seokchan Hong2, Jebum Won1, Oh Chan Kwon2, Ji Seon Oh2, Yong-Gil Kim2, Chang Keun Lee2 and Bin Yoo2, 1Division of Rheumatology, Department of Internal Medicine,, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of (South), 2Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of (South)

    Background/Purpose: Although febuxostat has been widely used for lowering uric acid levels because of its renal safety compared with allopurinol, data on the hepatic safety…
  • Abstract Number: 2235 • 2018 ACR/ARHP Annual Meeting

    Monosodium Urate Deposition Distribution in the Knees, Hands, and Feet of Treated Gout Patients: A Dual-Energy CT Study

    Chio Yokose1, Nicola Dalbeth2, Savvas Nicolaou3, Scott Baumgartner4, Jia Hu5, Maple Fung4, F. Joseph Simeone6 and Hyon K. Choi1, 1Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, 2University of Auckland, Auckland, New Zealand, 3Radiology, University of British Columbia, Vancouver, BC, Canada, 4Formerly Ardea Biosciences, San Diego, CA, 5Heron Therapeutics, San Diego, CA, 6Department of Radiology, Massachusetts General Hospital, Boston, MA

    Background/Purpose: Prior studies have demonstrated that monosodium urate (MSU) deposits on dual-energy CT (DECT) are commonly found in joints as well as tendons of the…
  • Abstract Number: 2236 • 2018 ACR/ARHP Annual Meeting

    Contemporary Comorbidity Burden of Gout and Hyperuricemia in the US during the Past Decade (National Health And Nutrition Examination Survey [NHANES] 2007-2016)

    Michael Chen-Xu1, Chio Yokose2, Michael Pillinger3 and Hyon K. Choi2, 1General Medicine, Wairarapa District Health Board, Masterton, New Zealand, 2Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, 3Medicine/Rheumatology, NYU School of Medicine, New York, NY

    Background/Purpose: Precise estimates of the comorbidity burden of gout and hyperuricemia are critical as their presence has important implications for the treatment of both gout…
  • Abstract Number: 2237 • 2018 ACR/ARHP Annual Meeting

    Prevalence of Urate-Lowering Therapy Use and Target Urate Level Achievement Among Gout Patients in the United States (National Health And Nutrition Examination Survey [NHANES] 2007-2014)

    Michael Chen-Xu1, Chio Yokose2, Michael Pillinger3 and Hyon K. Choi2, 1General Medicine, Wairarapa District Health Board, Masterton, New Zealand, 2Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, 3Medicine/Rheumatology, NYU School of Medicine, New York, NY

    Background/Purpose: To determine the latest national prevalence of urate-lowering therapy (ULT) use and achievement of a therapeutic target serum urate level (SUL) in gout patients,…
  • Abstract Number: 2238 • 2018 ACR/ARHP Annual Meeting

    Non-Coding Urate-Associated Variants Function in a Conserved Lincrna Regulatory Domain That Alters MAF transcription

    Megan Leask1, Tony R. Merriman1, Amy Dowdle1, Hamish Salvesen1, Ruth Topless1, Tayaza Fadason2, Wenhua Wei1, William Schierding2, Justin O'Sullivan2 and Julia Horsfield1, 1University of Otago, Dunedin, New Zealand, 2University of Auckland, Auckland, New Zealand

    Background/Purpose: Genome-wide association studies (GWAS) have revealed that the large majority of disease-associated single nucleotide polymorphisms (SNPs) are located in the non-coding regions of the…
  • Abstract Number: 2239 • 2018 ACR/ARHP Annual Meeting

    Tenocytes Extracted from Rotator Cuff Tendons Are Able to Induce Mineral Deposition in Vitro and Express Genes Related to a Chondrocyte Differentiation

    Christelle Darrieutort-Laffite1,2, Paul Arnolfo1, Benoit Le Goff1,2 and Frédéric Blanchard1, 1INSERM U1238, PHY-OS Laboratory, Nantes, France, 2Rheumatology, Nantes University Hospital, Nantes, France

    Background/Purpose: Calcific tendonitis is a frequent cause of shoulder pain. The calcium deposits are composed of carbonated apatite and their origin stays still largely unknown.…
  • Abstract Number: 2240 • 2018 ACR/ARHP Annual Meeting

    Hip Involvement in Patients with Gout: Results of an Ultrasound Study

    Andrea Di Matteo1, Emilio Filippucci1, Edoardo Cipolletta2, Alice Musca3, María Victoria Martire4, Daniele Pierucci1, Eleonora Di Donato1 and Walter Grassi1, 1Polytechnic University of Marche, Rheumatology Clinic, Jesi, Italy, 2Polytechnic University of Marche, Rheumatology Clinic, jesi, Italy, 3Internal Medicine and Rheumatology Department, Bucharest, Romania, 4Instituto Médico Platense, La Plata, Argentina

    Background/Purpose: Although considered as uncommon, the hip represents one of the possible targets of gout. To date, hip involvement in patients with gout has been…
  • Abstract Number: 2241 • 2018 ACR/ARHP Annual Meeting

    What Can Variation in Clinical Practice Teach Us about Treatment Strategies for Patients with Gout?

    Ritch te Kampe1, Caroline van Durme1, Matthijs Janssen2, Annelies Boonen1 and Tim Jansen2, 1Department of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands, Maastricht, Netherlands, 2Department of Rheumatology, VieCuri Medical Center, Venlo, The Netherlands, Venlo, Netherlands

    Background/Purpose: To improve quality of care for patients with gout, two hospitals in the Netherlands initiated a protocolized gout clinic. One clinic adopted a patient-centred…
  • Abstract Number: 2242 • 2018 ACR/ARHP Annual Meeting

    Cardiovascular Outcomes of Treatment with Febuxostat and Allopurinol in Gout Patients with Kidney Disease

    William B. White1 and Lhanoo Gunawardhana2, 1Cardiology, University of Connecticut School of Medicine, Farmington, CT, 2Takeda Pharmaceuticals International, Deerfield, IL

    Background/Purpose: The Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Comorbidities (CARES) trial demonstrated that major cardiovascular (CV) outcomes on febuxostat…
  • Abstract Number: 2243 • 2018 ACR/ARHP Annual Meeting

    Sex Difference of the Association between Serum Urate and Blood Pressure in Young Adults

    Angelo Gaffo1, Elizabeth J. Rahn2, Tanja Dudenbostel1, Amy S. Mudano1, Peng Li3, David T. Redden3, Stephanie Biggers1, Phillip J. Foster2, Paul M. Muntner4, Suzanne Oparil5, David A. Calhoun5 and Kenneth Saag1, 1University of Alabama at Birmingham, Birmingham, AL, 2Department of Medicine, Division of Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, 4Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 5Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Serum urate (sUA) has been associated with blood pressure in most but not all studies. This study aims to test whether there are sex…
  • Abstract Number: 2244 • 2018 ACR/ARHP Annual Meeting

    Comparison of an Interactive Voice Response (IVR) to Smart Phone App to Determine Patient Preference for Reporting Gout Flares

    Nada Elmagboul1, Brian W Coburn2, Kenneth Saag1, Phillip J. Foster3, Amy S. Mudano1, Joshua A. Melnick4, Debra A Bergman2, Shuo Yang1, David T. Redden5, Lang Chen1, Filby Cooper1, Jeffrey R. Curtis1 and Ted R. Mikuls6, 1University of Alabama at Birmingham, Birmingham, AL, 2Division of Rheumatology, VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, 3Department of Medicine, Division of Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 4Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 5Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, 6Internal Medicine, Division of Rheumatology, VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Gout flares are a major cause of morbidity and are an important outcome in clinical studies. Significant limitations for timely flare ascertainment exist, and…
  • Abstract Number: 2245 • 2018 ACR/ARHP Annual Meeting

    Lubricin/Proteoglycan 4 (PRG4) Inhibits NLRP3 Inflammasome Assembly in Monosodium Urate (MSU)-Crystal Induced Arthritis.

    Anthony M. Reginato1, Changqi Sun2, Elsaid A. Khaled3, Tannin A. Schmidt4, Olin D. Liang5 and Gregory D Jay6, 1Division of Rheumatology, Rhode Island Hospital, Providence, RI, 2Division of Rheumatology, Rhode Island Hospital, Providence, MA, 3Department of Biomedical and Phramaceutical Science, Chapman University School of Pharmacy, Irvine, CA, 4Biomedical Engineering, University of Connecticut Health Center, Framington, CT, 5Division of Hematology/Oncology, Rhode Island Hospital, Providence, RI, 6Department of Emergency Medicine, Rhode Island Hospital, Providence, RI

    Background/Purpose: Lubricin/proteoglycan-4 (PRG4) is a mucinous glycoprotein secreted by synovial fibroblast and superficial zone chondrocytes. PRG4 has a multifaceted homeostatic role in the joint including…
  • « Previous Page
  • 1
  • …
  • 1333
  • 1334
  • 1335
  • 1336
  • 1337
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology